The U.S. Food and Drug Administration issued guidelines on Thursday for the development of a new device to treat type 1 diabetes that will give manufacturers ‘maximum flexibility’ in getting it to U.S. patients.
The U.S. Food and Drug Administration issued guidelines on Thursday for the development of a new device to treat type 1 diabetes that will give manufacturers ‘maximum flexibility’ in getting it to U.S. patients.
